Latest Safety News

Page 54 of 146
LTR Pharma Limited (ASX, LTP) reported significant progress in FY25, advancing its novel intranasal treatments for erectile dysfunction and expanding its commercial footprint in Australia and the US. The company secured key partnerships and capital raises, positioning itself for regulatory milestones and global market entry.
Ada Torres
Ada Torres
29 Aug 2025
Virgin Australia has delivered a strong FY25 performance with pro forma underlying NPAT up 27.8%, meeting prospectus targets, while reaffirming its FY26 outlook amid operational improvements and fleet expansion.
Victor Sage
Victor Sage
29 Aug 2025
PYC Therapeutics has reported promising safety data from the initial phase of its clinical trial for PYC-003, an RNA therapy targeting the root cause of Polycystic Kidney Disease. The findings, presented at the ANZSN conference, highlight the drug’s tolerability in healthy volunteers, paving the way for further clinical development.
Ada Torres
Ada Torres
29 Aug 2025
Memphasys Limited reported a net loss of AUD 4.94 million for FY25 while accelerating commercial efforts for its Felix System and advancing its RoXsta diagnostics platform.
Ada Torres
Ada Torres
29 Aug 2025
PARKD Limited reported a remarkable 218% increase in revenue to $11.83 million for FY25, driven by key construction projects and new licensing agreements. The company narrowed its loss by 74%, signaling progress in commercialising its modular construction technology.
Victor Sage
Victor Sage
29 Aug 2025
Mesoblast Limited has reported its FY2025 results, highlighting the FDA approval and US commercial launch of Ryoncil, its first mesenchymal stromal cell therapy, alongside a $102.1 million net loss and $161.6 million in cash reserves.
Ada Torres
Ada Torres
29 Aug 2025
Bhagwan Marine Limited has delivered a strong first year as an ASX-listed company with record net revenue and EBITDA growth, alongside its inaugural dividend declaration. The company is advancing growth in offshore energy, subsea, ports, and defence sectors while investing in innovation and fleet expansion.
Victor Sage
Victor Sage
29 Aug 2025
Metro Mining Limited delivered a remarkable turnaround in the first half of 2025, posting record bauxite shipments and a $119.8 million net profit after tax, reversing prior losses and impairments.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Bhagwan Marine Limited has reported record financial results for FY25, driven by strong growth across its core marine services and new sectors. The company also declared its inaugural fully franked dividend, signaling confidence in its strategic direction.
Victor Sage
Victor Sage
29 Aug 2025
RemSense Technologies posted a 107% revenue surge to $3.44 million in FY2025 alongside a 67% reduction in net loss, driven by operational efficiencies and strong client demand. The company achieved positive cash EBITDA and strengthened its global footprint with Tier 1 clients.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Noxopharm Limited reported a 36.5% increase in its annual loss to $4.88 million as it progressed preparations for its SOF-SKN™ clinical trial and secured $2.6 million through convertible notes. The biotech continues to invest heavily in its inflammation and oncology drug pipeline while managing liquidity and strategic partnerships.
Ada Torres
Ada Torres
29 Aug 2025
Wellard Ltd posts a net profit turnaround in FY2025 despite fleet downsizing, sells its last vessel, and plans to delist from the ASX while returning substantial capital to shareholders.
Ada Torres
Ada Torres
29 Aug 2025